2don MSN
She went to rehab for an eating disorder 4 times. Now she runs a $900 million treatment company.
Kristina Saffran was sent to a rehabilitation facility to fight her eating disorder. After a relapse, she went back. Then she went back twice more, for a total of seven months, over her freshman year ...
In a bid to expand its reach in the attention-deficit/hyperactivity disorder (ADHD) market, Collegium Pharmaceutical has struck a deal to ...
Now, adults who take these medications will be required to see a doctor in-person — every three months — starting May 16.
Paris Hilton was diagnosed with attention-deficit hyperactivity disorder in her 20s and is trying to raise awareness and ...
Over 22 million Americans are diagnosed with ADHD -- yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive(1) Firefly's AI-powered ...
Stimulant medications and non-stimulant medications affect brain chemistry through different mechanisms”— Dr. Stanford ...
A randomized controlled trial (RCT) published in Psychological Medicine demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using the digital therapy "attexis." ...
A randomized controlled trial (RCT) published today in Psychological Medicine demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using the digital therapy "attexis ...
A health trust has issued an update after the decision to pause its referrals for autism and ADHD diagnoses in Lancashire received widespread backlash. Lancashire and South Cumbria Integrated Care ...
Onyda XR is an extended-release liquid version of clonidine, a generic medication that has been trusted in various medical applications for decades. Unlike immediate-release versions of clonidine, ...
What they found was that the device was safe to use but provided no significant relief of symptoms in the group receiving the treatment, compared with the short-stimulation cohort. The symptoms they ...
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who receive long-term methylphenidate treatment face increased risks for overweight or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results